-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UFV0qcQHO/HomMGlEGloF/W3PCu7jMyxoG/LYrVbMEV2Z6MQqI3Au8+wv7xhzEdG D9IhHWIvuQKPK6Hc83gahw== 0000866105-09-000006.txt : 20090922 0000866105-09-000006.hdr.sgml : 20090922 20090921173645 ACCESSION NUMBER: 0000866105-09-000006 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 ITEM INFORMATION: Securities Act Section 4(6) FILED AS OF DATE: 20090922 DATE AS OF CHANGE: 20090921 EFFECTIVENESS DATE: 20090922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMPLIMED CORP CENTRAL INDEX KEY: 0000866105 IRS NUMBER: 860625176 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-59001 FILM NUMBER: 091079598 BUSINESS ADDRESS: STREET 1: 4380 NORTH CAMPBELL AVENUE STREET 2: SUITE 205 CITY: TUCSON STATE: AZ ZIP: 85718 BUSINESS PHONE: 520-529-1000 MAIL ADDRESS: STREET 1: 4380 NORTH CAMPBELL AVENUE STREET 2: SUITE 205 CITY: TUCSON STATE: AZ ZIP: 85718 D/A 1 primary_doc.xml X0502 D/A LIVE 0000866105 AMPLIMED CORP 4380 NORTH CAMPBELL AVENUE SUITE 205 TUCSON AZ 85718 520-529-1000 None DELAWARE Corporation true Chris Richied 4380 North Campbell Avenue Suite 205 Tucson AZ 85718 Executive Officer John M. Holliman 4380 North Campbell Suite 205 Tucson AZ 85718 Director Ronald Garren 4380 North Campbell Suite 205 Tucson AZ 85718 Director Harry A. George 4380 North Campbell Avenue Suite 205 Tucson AZ 85718 Director Joel Smolen 4380 North Campbell Avenue Suite 205 Tucson AZ 85718 Director Robert T. Dorr 4380 North Campbell Avenue Suite 205 Tucson AZ 85718 Executive Officer Director Randolph Steer 4380 North Campbell Avenue Suite 205 Tucson AZ 85718 Director Steve Steinman 4380 North Campbell Avenue Suite 205 Tucson AZ 85718 Executive Officer William Remers 4380 North Campbell Avenue Suite 205 Tucson AZ 85718 Executive Officer Biotechnology Decline to Disclose 06 46 true 0000866105-09-000005 2009-08-17 false true true false 500 DPEC Capital, Inc. 10737 None None 135 Fifth Avenue 10th Floor New York NY 10010 NY 12000000 3919043 8080957 false 8 0 32500 true The Company paid $32,500 in cash to the DPEC Capital, Inc. In addition, the Company has paid 22,649 warrants to purchase Series D Preferred Stock in the Company to DPEC Capital, Inc. 0 true A portion may be used to pay accrued salaries to executives, but the exact amount, if any, is not yet determinable. false AMPLIMED CORP Chris Richied Chris Richied Chief Financial Officer 2009-09-21 -----END PRIVACY-ENHANCED MESSAGE-----